INS and type 2 diabetes mellitus: Previous studies demonstrate that patients with insulin-treated T2DM, but low postprandial C-peptide levels, have markedly increased glucose variability and incidence of hypoglycemia and hyperglycemia compared with those who retained C-peptide [13].